RTX: Maintain Hold; Await $192 Support Test with Confirmation Signals Before Reconsidering Overweight
RTX retains a compelling long-term business case with record Q2 2026 revenue of $24.7B (+14.5% YoY), 150 bps operating-margin expansion, 28.7% EPS growth, ~$9.9B TTM free cash flow, more than $8B debt retirement, and $289B backlog. However, the current tactical setup—lower highs at $225/$212/$201/$198, price below 10-EMA/50-SMA/VWMA, MACD histogram negative at -2.09, RSI at 33 with no bullish divergence, and an impending death cross—does not justify adding capital at $198 with only 3% distance to $192 support and 6% distance to $209-210 resistance. The prior RTX Overweight delivered only +0.3% absolute and +0.9% alpha, validating avoidance of a bearish structural-floor mistake but not proving restrictive add triggers will activate. A disciplined Hold best captures strong fundamentals without creating false asymmetry.
| Position | Action |
|---|---|
| RTX remains within $192-$209-210 range without breakdown | Maintain neutral benchmark weight, do not add fresh capital |
| RTX breaks $192 on volume above 1.5x average | Trim 25-33% of position |
| $185 support fails | Exit remaining tactical RTX exposure; move toward $170-175 becomes more likely |
| RTX reclaims $209-210 | Mark trend repair; reassess Overweight potential |
The 12.7% pullback from the August high is a healthy, shallow correction within a structural uptrend, presenting a generational buying opportunity as RTX trades cheaper while delivering record quarterly revenue, expanding margins, and accelerating earnings on the back of a $289B backlog that provides multi-year visibility.
| Indicator | Value | Signal |
|---|---|---|
| 10-EMA | 202.82 | bearish |
| 50-SMA | 207.83 | bearish |
| 200-SMA | 192.21 | neutral |
| MACD | −3.40 | bearish |
| MACD Histogram | −2.09 | bearish |
| RSI | 33.05 | neutral |
| Bollinger Upper | 227.38 | bearish |
| Bollinger Middle | 209.94 | bearish |
| Bollinger Lower | 192.50 | neutral |
| ATR | 4.09 | neutral |
| VWMA | 206.10 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: RSI bullish divergence develops
Then: Second confirmation signal toward Overweight
Revenue and earnings are accelerating with record-high quarterly performance and margin expansion
↩ rebuts: “Cyclical Commercial Aerospace Exposure”
EV: +13.6% to August high of $225 (3-6 month); +21.2% to $240+ (12 month) · concedes: The 10-EMA has rolled over and MACD histogram is negative with poor short-term momentum; The stock closed below the 10-EMA and 50-SMA; Receivables did grow to $1.69B in Q2 2026, though this is standard for defense primes with milestone-based billing, not a sign of collection problems; Negative tangible book value is accurate, though it is true for every major defense prime due to M&A history
A quality franchise can still be a poor investment at the wrong price, in the wrong technical setup, with the wrong sentiment backdrop — the risk/reward is roughly symmetric with a slight downside tilt as the chart is broken across multiple timeframes and next major support at $192 is only 3% away versus 6% to next resistance at $210.
EV: -$193 (probability-weighted target ~$193, representing ~3% downside from current ~$198) · concedes: RTX is a quality franchise with real backlog (even if headline number is fuzzier than presented); Margins are expanding; Defense secular story is intact; The company is not struggling to collect in the sense that revenue is accelerating — though cash conversion is weakening; Higher rates do help contracted multi-year cash flows on a relative basis vs. growth stocks
→ vs conservative: Conservative view 'completely falls apart' given Q2 2026 record revenue of 24.7 billion dollars (up 14.5% YoY), operating margin expanding 150 basis points, EPS growth of 28.7 percent, FCF inflecting to nearly 10 billion, 8 billion dollars of debt retired, and approximately 289 billion dollars in order backlog exceeding market cap
→ vs conservative: Conservative 'buying fear right at the moment when smart money is about to step in' — price 3% above 200-day SMA at 192 has been structural floor for entire bull leg
→ vs conservative: Beta of 0.29 makes this 'practically a bond proxy with growth attached' — risk-adjusted return profile is exceptional
→ vs conservative: The 'what about risk' card is directly challenged: downside to 185 is roughly 7%, upside to 225 is 13.5%, with fundamental story continuing to compound
→ vs neutral: Waiting for confirmation at 192 (reversal candle with volume, RSI divergence, MACD flattening) is 'textbook world' but in practice signal fires AFTER move has already started — clean reversal candle means price back at 205 or 210 chasing the move
→ vs neutral: Forward P/E of 25.2x is anchored to static growth assumption; backlog conversion acceleration means PEG of 2.33 is 'dramatically overstated'
→ vs neutral: Hold at neutral weighting is 'worst of both worlds' — fully exposed on downside without positioned upside; 'that's not risk management, that's hope'
→ vs neutral: Valuation objection is 'weakest part of Hold thesis' — discipline means buying excellence when market panics, not waiting for confirmation that costs 5-10% of upside
| Latest Close | 198.12 | bearish |
| Daily Volume | 2,624,059 | bearish |
| 52-Week High (Aug 18) | 225.49 | bearish |
Support: 192.5 · 192.21 · 185.76 | Resistance: 209.94 · 215.93 · 225.49
RTX exhibits a uniformly bearish technical posture across trend, momentum, and volume dimensions. The 10-EMA is rolling over sharply and is about to cross below the 50-SMA (gap ≈ $5.01), which would generate a classic death-cross continuation sell signal. The 200-SMA at $192.21 is the critical long-term support; a sustained close below $192.50 (Bollinger lower band) would signal new local weakness toward $185.76. Base case (60% probability) targets a test of the 200-SMA zone before basing, while a bear case (25%) breakdown targets $185. Bull case (15%) requires price reclaiming the 10-EMA ($202.82) on rising volume with RSI >45 and MACD histogram flattening. ATR of 4.09 implies a reasonable 2-ATR (~$8) trailing stop for risk management.
Market Cap
$267.02 billion
P/E Ratio (TTM)
34.82x
Forward P/E
25.22x
PEG Ratio
2.33
Price / Book
4.02x
EPS (TTM)
$5.69
Forward EPS
$7.86
Dividend Yield
1.48%
Beta
0.287
50-Day Avg
$208.09
200-Day Avg
$193.33
52-Week High
$226.88
52-Week Low
$154.36
Revenue (TTM)
$93.5B
Gross Margin (TTM)
20.3%
Operating Margin (TTM)
12.7%
EBITDA (TTM)
$15.9B
Net Income (TTM)
$7.74B
Net Margin (TTM)
8.3%
Return on Equity
12.3%
Return on Assets
4.2%
Revenue 3Y CAGR
~9.7%
EPS 3Y CAGR
~12.3%
FCF FY24 to FY25 Growth
+90%
Total Assets
$174.0B
Stockholders' Equity
$66.4B
Total Debt
$38.9B
Cash and Equivalents
$8.3B
Net Debt
$29.1B
Current Ratio
1.01
Operating Cash Flow (TTM)
~$14.7B
Free Cash Flow (TTM)
$9.88B
CapEx (TTM)
$3.12B
Dividends Paid (TTM)
~$3.72B
Book Value
$49.25
Strengths
Concerns
RTX Corporation is a global aerospace and defense conglomerate formed via the 2020 merger of United Technologies and Raytheon, now operating three core segments: Collins Aerospace (avionics, interiors, aerostructures), Pratt & Whitney (aircraft engines), and Raytheon (defense systems, missiles, sensors, radars). The company demonstrates strong fundamental momentum with Q2 2026 record quarterly revenue of $24.7B, 14.5% year-over-year growth, and 150 bps margin expansion driven by commercial aerospace recovery and cost discipline post-spin-offs. Key risks include rich valuation (34.8x P/E, 2.33x PEG), growing receivables outpacing revenue, negative tangible book value from goodwill-heavy balance sheet, and cyclical defense/commercial aerospace exposure.
Macro: Prediction-market implied probabilities (Polymarket, 9/10): 93% probability of no Fed rate cuts in 2026 (+4pp WoW), 8% US recession probability by end of 2026 (+1.5pp WoW), 0% probability of 6+ cuts. Higher-for-longer rates favor companies with pricing power and contracted backlogs; no-recession base case keeps defense budgets funded and commercial aero recovery on track. 30-year Treasuries seeing strong investor demand; long-end rally despite yields pop supports DCF on long-cycle defense assets. Sticky but not accelerating inflation confirmed by gold/PPI dynamics.